Dernières nouvelles du
monde de Reformulary

Cannabis Standard Insights, Issue #3 published by Reformulary Group

Reformulary Group Announces Partnership with VIVO Cannabis

Reformulary Group launches COVID-19 DEW Report

New study underscores importance of medical cannabis rating system

Reformulary 2019 Year in Review

Cannabis Standard Insights, Issue #2 published by Reformulary Group

[Anglais] CIX TOP 20 Early and CIX TOP 10 Growth announced Reformulary as a CIX TOP 20 Early, one of...

Letter to the editor: Pharmacare – not all Canadians, not all drugs

Cannabis Standard Insights, Issue #1 published by Reformulary Group

The challenges with medical cannabis in the workplace

Reformulary Group creates online community platform for info on medical cannabis

Reformulary Group launches medical cannabis formulary